Drug firms donate compounds for anti-HIV gel

Towie, Narelle
November 2005
Nature;11/3/2005, Vol. 438 Issue 7064, p6
Academic Journal
Reports that two drug companies have given away rights to two key compounds for anti-HIV gel. Protection of women using the gel; Number of lives that could be saved with its use; Clinical trials in Africa on monkeys.


Related Articles

  • Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials. Shedlock, Devon J.; Silvestri, Guido; Weiner, David B. // Nature Reviews Immunology;Oct2009, Vol. 9 Issue 10, p717 

    Rhesus macaques are an important animal model for the study of human disease and the development of vaccines against HIV and AIDS. HIV vaccines have been benchmarked in rhesus macaque preclinical challenge studies using chimeric viruses made up of parts of HIV and simian immunodeficency viruses....

  • Parietal activity and the perceived direction of ambiguous apparent motion. Williams, Ziv M; Elfar, John C; Eskandar, Emad N; Toth, Louis J; Assad, John A // Nature Neuroscience;Jun2003, Vol. 6 Issue 6, p616 

    We recorded from parietal neurons in monkeys (Macacca mulatta) trained to report the direction of an apparent motion stimulus consisting of regularly spaced columns of dots surrounded by an aperture. Displacing the dots by half their inter-column spacing produced vivid apparent motion that could...

  • Funding for HIV network extended.  // CMAJ: Canadian Medical Association Journal;06/01/97, Vol. 156 Issue 11, p1524 

    Reports on the extension of the federal government's stable funding for the Canadian HIV Trials Network (CTN). Research projects of the organization; National director of the group.

  • Hundreds enrolled in Canadian HIV trials.  // CMAJ: Canadian Medical Association Journal;06/15/97, Vol. 156 Issue 12, p1691 

    Reports on the Canadian volunteers enrolled in a protease inhibitor study that is the first large-scale collaborative clinical trial involving the Canadian HIV Trials Network (CTN) and American researchers. Comparison of the effectiveness of a 2-drug combinations with AZT against the highest...

  • Calendar of Events.  // Applied Clinical Trials;May2010, Vol. 19 Issue 5, p60 

    A calendar of events related to pharmaceutical industry from September 1-28, 2010 is presented including the Clinical Trial Administration in Buckingham, England, the Pharma or Biotech Internal Audit Summit in Philadelphia, Pennsylvania, and the Good Manufacturing Practice in Pharmaceutical...

  • IS PURDUE the nexyt big pharma company? Wall, J. K. // Indianapolis Business Journal;11/4/2013, Vol. 34 Issue 36, p17A 

    The article features Indiana-based pharmaceutical company Purdue and mentions the innovation at its drug discovery equipment. It discusses the Purdue Drug Discovery Initiative and notes the effort of the company in conducting clinical trials for the discovery and manufacture of drugs. It also...

  • Using a Systematic Approach to Select Critical Process Parameters. Little, Thomas A. // Pharmaceutical Technology;Nov2012 Supplement Analytical and Bioanalytical testing, pS44 

    The article discusses critical process parameters (CPPs) which are important for drug development and process validation in manufacturing unit operation. It suggests determining critical quality attributes (CQAs) for drug products as it is important for drug product quality and clinical trials....

  • More Surprises Stem from RV144. Jill Kresge, Kristen // VAX;Sep2011, Vol. 9 Issue 5, p1 

    The article reports that the RV144 vaccine has provided evidence of vaccine-induced protection against human immunodeficiency virus. As stated, various other clinical trials are undergoing in order to see whether vaccines like VAX003 and 004 also have same immune responses to the prime-boost...

  • A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-noninfected... Perry, R.T.; Plowe, C.V.; Koumaré, B.; Bougoudogo, F.; Kotloff, K.L.; Losonsky, G.A.; Wasserman, S.S.; Levine, M.M. // Bulletin of the World Health Organization;1998, Vol. 76 Issue 1, p63 

    Provides information on randomized clinical trials conducted in Mali on adults who are infected with the Human Immunodeficiency Virus (HIV), with focus on the use of a single dose of live oral cholera vaccine. Details on the seventh cholera pandemic caused by Vibrio cholerae; Methodology used...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics